Completed OBSERVATIONAL NCT03723317

Associated Balance of Risk Score - Comprehensive Complication Index for the Prediction of Post-transplant Survival

Associated Balance of Risk Score - Comprehensive Complication Index for the Prediction of Long-term Survival After Liver Transplantation

Sponsor: European Hepatocellular Cancer Liver Transplant Group

Conditions Liver Cirrhosis Liver Diseases Liver Failure Transplant Failure

Interventions Liver transplantation

Updated 4 times since 2018 Last updated: Oct 26, 2018 Started: Jan 15, 2018 Primary completion: Oct 15, 2018 Completion: Oct 15, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03723317, this observational or N/A phase trial focuses on Liver Cirrhosis and Liver Diseases and remains completed. Sponsored by European Hepatocellular Cancer Liver Transplant Group, it has been updated 4 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Nov 2018 — Jan 2021 [monthly]

Completed

First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

European Hepatocellular Cancer Liver Transplant Group

Data source: European Hepatocellular Cancer Liver Transplant Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Brussels, Belgium